Aurobindo Pharma Gets First USFDA Approval for Generic Anaesthesia
Aurobindo Pharma's subsidiary, Eugia Steriles, has received its first product approval from the USFDA for Lidocaine Hydrochloride Injection, a generic anaesthesia medication.
New Delhi, Sep 11 (PTI) Aurobindo Pharma on Wednesday said its unit has received the first product approval from the US Food and Drug Administration for a generic anaesthesia medication.
The new injectable facility of Eugia Steriles, a subsidiary of Eugia Pharma Specialities and a stepdown unit of the company, situated at Anakapalli District of Andhra Pradesh was inspected by the US FDA from March 28 to April 5 this year.
The plant has now received its first product approval from the USFDA for Lidocaine Hydrochloride Injection, Aurobindo Pharma said in a regulatory filing.
Shares of Aurobindo Pharma on Wednesday ended 0.74 per cent down at Rs 1,507.20 apiece on the BSE.
The new injectable facility of Eugia Steriles, a subsidiary of Eugia Pharma Specialities and a stepdown unit of the company, situated at Anakapalli District of Andhra Pradesh was inspected by the US FDA from March 28 to April 5 this year.
The plant has now received its first product approval from the USFDA for Lidocaine Hydrochloride Injection, Aurobindo Pharma said in a regulatory filing.
Shares of Aurobindo Pharma on Wednesday ended 0.74 per cent down at Rs 1,507.20 apiece on the BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone-Idea-L
- 11.65 (+ 3.56)
- 106569808
- Alstone-Textiles
- 0.28 ( -3.45)
- 44174217
- Mangalam-Industrial
- 0.88 ( -2.22)
- 39176360
- Sunshine-Capital
- 0.27 (+ 3.85)
- 35953745
- GMR-Airports
- 104.40 (+ 6.37)
- 30448205
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback